Finally, follow the money. The study declared it had no funding. In reality it did (of course), and in all likelihood that funding ultimately came from China and had strings attached to promote use of the Sinovac vaccine. Perhaps later I'll post the trail that leads to this probable conclusion.
In November of 2020, the plan of the current FUD study was revealed:
https://trialsjournal.biomedce…0.1186/s13063-020-04813-1
It actually mentions it's source of funding :
This study is funded by the Ministry of Health of the Province of Corrientes, Argentina, which will have no interference in the selection of participants, data collection, analysis, interpretation of the results, or the final publication of the study.
(Notice it didn't say 'the Ministry of Health' wouldn't have influence over the study protocol!)
But what about the Ministry of Health for Corrientes, and where might it be getting the money for this study?
From https://www.bcie.org/en/news-a…rtura-y-acceso-a-la-salud
my bold :
Tegucigalpa, September 24, 2020. - The Central American Bank for Economic Integration (CABEI) and the Government of the Republic of Argentina, signed a loan agreement for an amount of US$32.0 million to finance the implementation of the Program to Support the Strategy for Expansion of Health Coverage and Access.
The contract was signed by CABEI's Executive President, Dr. Dante Mossi and the Secretary of International Financial Relations for Development of the Secretariat of Strategic Affairs of the Presidency of the Nation, Mr. Christian Asinelli.
The loan will help the Ministry of Health and the Provincial Ministries of Health strengthen their institutional capacity to provide public health services by financing improvements to the information systems for the vaccinated population and optimizing the conditions for vaccine supply and use in order to support universal health service coverage in Argentina. The total amount of the program is US$40.0 million.
As a result of the interventions that will be carried out with the program, a total of 7,724,553 people are expected to be vaccinated per year, 58.0% of whom are women. The Program's area of influence will include the provinces of Buenos Aires, La Rioja, Chubut, Corrientes, Jujuy, Neuquén and San Juan for the construction or improvement of the vaccine warehouses, foreseeing a nationwide reach with the implementation of the appropriate technological platform.
It is estimated that the implementation of this program will generate savings in the Argentine State, derived mainly from the decrease in costs for consultations, medicines, studies, and hospitalization of people affected by immunopreventable diseases.
The granting of this loan ratifies the commitment that CABEI has with one of its partner countries, and the interest that Argentina has in promoting health, social and prevention programs to improve the welfare of its population.
********
Notice the 'commitment' that CABEI has with one of its partner countries. Who might that mysterious partner country be?
From http://www.cabeifund.com,
FUND SPONSOR. . .
The Central American Bank for Economic Integration (CABEI) is a multilateral development bank owned by ten governments: its Founding Members include Costa Rica, El Salvador, Guatemala, Honduras, and Nicaragua; and its Extra-Regional Members include Argentina, Republic of China, Colombia, Mexico and Spain.
Notice that the "Republic of China" listed is the one and only non Latin country there, the probable reason why it is not named outright as the 'partner country'. Not exactly a matter of Latin pride.
But China has money and influence and it has a vaccine for Argentina, although that vaccine has some issues.
http://www.asianews.it/news-en…COVID-vaccines-52870.html
04/14/2021
Doubts in Argentina about the effectiveness of Chinese anti-COVID vaccines
by Silvina Premat
Argentina relies on Sinopharm, whose level of effectiveness has yet to be verified. Sinovac used in Chile and Brazil has a success rate just above 50 per cent. For immunologist Guillermo Docena, any vaccine is better than nothing during a pandemic.
In summary, based on the FUD study's avoidable shortcomings, it isn't much of a stretch to hypothesize that the architects of the current FUD study had a 'commitment' to promote Chinese vaccines at the expense of potentially competitive Covid treatments like Ivermectin.